ManreetKaurKanwarMD
Cardiology • Pittsburgh, PAAdult Congenital Heart Disease, Heart Failure & Transplantation, Interventional Cardiology
Physician
Dr. Kanwar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
320 E North Ave
Pittsburgh, PA 15212Phone+1 412-359-6550Fax+1 412-359-6494
Education & Training
Ascension St John HospitalFellowship, Cardiovascular Disease, 2007 - 2010- Ascension St John HospitalResidency, Internal Medicine, 2004 - 2007
Government Medical College PatialaClass of 2002
Certifications & Licensure
IL State Medical License 2024 - 2026
PA State Medical License 2010 - 2024
CA State Medical License 2010 - 2023
MI State Medical License 2004 - 2011
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Clinical Trials
- The ARIES HeartMate 3 Pump IDE Study Start of enrollment: 2020 Jul 14
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Response by Bhimaraj et al to Letter Regarding Article, "Pitfalls in the World of Evidence-Based Medicine: Should IABP Be en-DANGER-ed by the DanGer Shock Trial?"Arvind Bhimaraj, Arthur R Garan, Manreet K Kanwar
Circulation. Heart Failure. 2025-02-21 - The Role of Heart Failure Physicians in the Contemporary Cardiac Intensive Care Unit: Impact on Heart Failure as a Career Choice Among Fellowship Applicants.Nir Uriel, Justin Fried, Adil Yunis, Kevin Clerkin, Dor Lotan
Journal of Cardiac Failure. 2025-02-13 - Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to Action.Shannon M Dunlay, Sean P Pinney, Anuradha Lala, Garrick C Stewart, Colleen McIlvennan
JAMA Cardiology. 2025-02-05
Press Mentions
Experts Hash Out Recommendations for Impella CP After DanGer ShockFebruary 14th, 2025- CareDx and Allegheny General Hospital Launch Research Study of Novel Test to Screen Heart Transplant Recipients for Signs of RejectionJuly 31st, 2014
- AHN Cardiovascular Institute at Allegheny General Hospital First in Region to Participate in International Clinical Trial for New Heart Failure TreatmentOctober 11th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
